Unlike prostate, colon and breast cancers, screening for lung cancer has not been very successful. This is largely because screening focuses on just one risk factor, smoking history, yet many people who develop the disease don't have a history of smoking. Now, scientists have made progress in developing a blood test that could help in flagging individuals who are at a higher risk of developing lung cancer.
The potential blood test represents a significant step forward in early detection. Early diagnosis is critical for improving survival rates, as lung cancer is often diagnosed at advanced stages when treatment options are limited. Current screening methods, primarily low-dose CT scans, are recommended only for heavy smokers aged 50 to 80, which excludes non-smokers and those with less exposure. However, approximately 20% of lung cancer deaths occur in people who have never smoked, highlighting the need for broader screening tools.
The new blood test aims to detect biomarkers—molecules in the blood that indicate the presence of cancer. By identifying these markers, the test could flag individuals at high risk regardless of smoking history. This approach could revolutionize lung cancer screening by making it accessible to a wider population, potentially saving thousands of lives each year.
As it gets easier to detect lung cancer earlier, new treatment modalities like those being developed by Calidi Biotherapeutics Inc. (NYSE American: CLDI) and therapies under development by other companies may become more effective. Early detection combined with advanced treatments could significantly improve patient outcomes.
The research is still in early stages, but experts are optimistic. The blood test could eventually become part of routine check-ups, similar to screenings for other cancers. While further studies are needed to validate its accuracy and reliability, this development brings hope for reducing lung cancer mortality.
For more information on the latest developments in biotechnology and life sciences, visit BioMedWire.
